Dear Doctor Letter (Rote-Hand-Brief) on Revlimid® (lenalidomide): Risk of liver diseases
2012.12.10
Active substance: lenalidomide
Information for health care professionals regarding the risk of liver diseases in connection with the use of Revlimid® (lenalidomide) in the presence of other risk factors.
(SPC Revlimid® - available in German only)
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN